Clinical meaning
Advanced oncology nursing requires understanding cancer at the cellular and molecular level, including the mechanisms of tumor growth, metastasis, and treatment resistance. Cancer develops through the accumulation of genetic mutations (oncogene activation, tumor suppressor gene loss) that confer the hallmarks of cancer: sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis induction, and invasion/metastasis activation. The tumor microenvironment — consisting of cancer-associated fibroblasts, immune cells, and vascular endothelium — actively supports tumor progression through growth factor secretion, immune evasion, and extracellular matrix remodeling. Chemotherapy targets rapidly dividing cells through cell cycle-specific (antimetabolites, vinca alkaloids) and cell cycle-nonspecific (alkylating agents, platinum compounds) mechanisms, with toxicity to normal rapidly dividing cells (bone marrow, GI epithelium, hair follicles) producing the characteristic side effects of myelosuppression, mucositis, and alopecia.
Exam relevance
Risk factors: - Cumulative chemotherapy toxicity (cardiotoxicity with anthracyclines) - Radiation-induced tissue damage (fibrosis, secondary malignancies) - Immune-related adverse events from immunotherapy - Tumor lysis syndrome risk with high tumor burden - Venous thromboembolism (Virchow triad enhanced in cancer) - Paraneoplastic syndromes - Psychosocial impact (depression, anxiety, body image changes) - Financial toxicity of cancer treatment